Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Adenomatous Polyposis Coli

sorafenib has been researched along with Adenomatous Polyposis Coli in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Azem, F; Fouks, Y; Goaz, S; Hasson, Y; Malcov, M; Sheiman, V1
Benech, N; Saurin, JC; Walter, T1
Coleman, EL; Cowper, SE; Leventhal, JS; Stein, SM1

Other Studies

3 other study(ies) available for sorafenib and Adenomatous Polyposis Coli

ArticleYear
Fertility preservation and PGT-M in women with familial adenomatous polyposis-associated desmoid tumours.
    Reproductive biomedicine online, 2021, Volume: 43, Issue:4

    Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Antineoplastic Agents; Female; Fertility Preservation; Fibromatosis, Aggressive; Humans; Oocyte Retrieval; Pregnancy; Preimplantation Diagnosis; Retrospective Studies; Sorafenib; Young Adult

2021
Desmoid Tumors and Celecoxib with Sorafenib.
    The New England journal of medicine, 2017, 06-29, Volume: 376, Issue:26

    Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Female; Fibromatosis, Aggressive; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Sorafenib; Tomography, X-Ray Computed

2017
Erythema Nodosum-like Eruption in the Setting of Sorafenib Therapy.
    JAMA dermatology, 2018, 03-01, Volume: 154, Issue:3

    Topics: Adenomatous Polyposis Coli; Aged; Antineoplastic Agents; Duodenal Neoplasms; Erythema Nodosum; Female; Fibroma; Humans; Middle Aged; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Sorafenib

2018